Skip to main content
Immuno-Biological Laboratories Co., Ltd. logo

Immuno-Biological Laboratories Co., Ltd. — Investor Relations & Filings

Ticker · 4570 ISIN · JP3921300004 T Manufacturing
Open in API
Filings indexed 65 across all filing types
Latest filing 2020-08-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 4570

About Immuno-Biological Laboratories Co., Ltd.

https://www.ibl-japan.co.jp/en/

Immuno-Biological Laboratories (IBL) is a research and development-focused company that develops, manufactures, and supplies immunological research reagents and in-vitro diagnostic products for the global life sciences community. The company's core offerings include a comprehensive range of ELISA kits, antibodies, and cell culture-related products. IBL specializes in several key research areas, including aging, neurodegenerative disorders, kidney diseases, inflammatory diseases, and glucose/lipid metabolism. A notable proprietary technology is the LipoSEARCH® lipoprotein analyzing system, which uses patented GP-HPLC methods. The company also provides customized services to support specific research requirements.

Recent filings

Filing Released Lang Actions
四半期報告書－第39期第1四半期(令和2年4月1日－令和2年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act. It contains detailed financial statements, including the balance sheet and income statement for the first quarter of the 39th fiscal period (April 1, 2020, to June 30, 2020). Since it provides comprehensive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2020
2020-08-14 Japanese
有価証券報告書－第38期(平成31年4月1日－令和2年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains detailed financial statements, management discussion, and corporate information for the fiscal year ending March 31, 2020. The header explicitly identifies it as a 'Securities Report' (有価証券報告書) submitted under the Financial Instruments and Exchange Act. FY 2020
2020-06-29 Japanese
四半期報告書－第38期第3四半期(令和1年10月1日－令和1年12月31日)
Interim / Quarterly Report
2020-02-14 Japanese
四半期報告書－第38期第2四半期(2019/07/01－2019/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, including the balance sheet, for the second quarter of the 38th fiscal period (April 1, 2019, to September 30, 2019). It includes management analysis, stock information, and audit review information. This fits the definition of an Interim/Quarterly Report (IR). H1 2020
2019-11-14 Japanese
四半期報告書－第38期第1四半期(2019/04/01－2019/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements (balance sheet, income statement) for the first quarter of the 38th fiscal period (April 1, 2019, to June 30, 2019). It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-08-14 Japanese
有価証券報告書－第37期(平成30年4月1日－平成31年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains detailed financial statements, business indicators, and management information for the fiscal year ending March 31, 2019. The header explicitly identifies it as a filing under the Financial Instruments and Exchange Act, Article 24, Paragraph 1. FY 2019
2019-06-28 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.